Resimmune
http://dbpedia.org/resource/Resimmune an entity of type: Thing
Resimmune or A-dmDT390-bisFv(UCHT1) is an experimental drug — an anti-T cell immunotoxin — that is being investigated for treatment of T cell blood cancers such as cutaneous T cell lymphoma (CTCL). It was developed by Doctors Neville, Woo, and Liu while at the National Institutes of Health (NIH) and is under exclusive license to Angimmune, LLC. The therapy has potential applications for lymphomas and T cell driven autoimmune diseases, including multiple sclerosis, and graft-versus-host disease following stem cell or bone marrow transplant.
rdf:langString
rdf:langString
Resimmune
xsd:integer
37461277
xsd:integer
1061345833
rdf:langString
none
rdf:langString
none
<second>
-3960.0
rdf:langString
A-dmDT390-bisFv
rdf:langString
Experimental
rdf:langString
rdf:langString
C
rdf:langString
Intravenous
rdf:langString
Resimmune
rdf:langString
Resimmune or A-dmDT390-bisFv(UCHT1) is an experimental drug — an anti-T cell immunotoxin — that is being investigated for treatment of T cell blood cancers such as cutaneous T cell lymphoma (CTCL). It was developed by Doctors Neville, Woo, and Liu while at the National Institutes of Health (NIH) and is under exclusive license to Angimmune, LLC. The therapy has potential applications for lymphomas and T cell driven autoimmune diseases, including multiple sclerosis, and graft-versus-host disease following stem cell or bone marrow transplant.
xsd:nonNegativeInteger
7698
rdf:langString
Resimmune